Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Tucker

Showing results (331-340 of 348) with videos related to

Pageof 35
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 7, 2000
Regioselective hydroxylation of debrisoquine by cytochrome P4502D6: implications for active site modellingT Lightfoot, S W Ellis, J Mahling, et al.
Neurology|December 17, 1998
A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol TeamK Kieburtz, D Simpson, C Yiannoutsos, et al.
Comparative Medicine|April 18, 2018
Cohousing Male Mice with and without Segmental Bone DefectsJeffrey D Rytlewski, Paul J Childress, David C Scofield, et al.
Biochemical Pharmacology|June 9, 2004
Cloning and functional expression of a novel marmoset cytochrome P450 2D enzyme, CYP2D30: comparison with the known marmoset CYP2D19Hiroyuki Hichiya, Shino Kuramoto, Shigeo Yamamoto, et al.
The Biochemical Journal|January 22, 2000
Evidence that serine 304 is not a key ligand-binding residue in the active site of cytochrome P450 2D6S W Ellis, G P Hayhurst, T Lightfoot, et al.
Platelets|May 16, 2017
Platelet reactivity influences clot structure as assessed by fractal analysis of viscoelastic propertiesRebecca B Knowles, Matthew J Lawrence, Plinio M Ferreira, et al.
Journal of Thrombosis and Haemostasis : JTH|August 30, 2008
Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2P C J Armstrong, N J Truss, F Y Ali, et al.
Current Drug Metabolism|February 3, 2007
Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liverZoe E Barter, Martin K Bayliss, Philip H Beaune, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 4, 2024
Engineering a Mesoporous Silicon Nanoparticle Cage to Enhance Performance of a Phosphotriesterase Enzyme for Degradation of VX Nerve AgentYi-Sheng Lu, Eduardo Reynoso Moreno, Yubin Huang, et al.
Circulation|December 11, 2014
Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugsBlerina Ahmetaj-Shala, Nicholas S Kirkby, Rebecca Knowles, et al.
Pageof 35

Showing results (331-340 of 348) with videos related to

Sort By:
Pageof 35
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 7, 2000
Regioselective hydroxylation of debrisoquine by cytochrome P4502D6: implications for active site modellingT Lightfoot, S W Ellis, J Mahling, et al.
Neurology|December 17, 1998
A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol TeamK Kieburtz, D Simpson, C Yiannoutsos, et al.
Comparative Medicine|April 18, 2018
Cohousing Male Mice with and without Segmental Bone DefectsJeffrey D Rytlewski, Paul J Childress, David C Scofield, et al.
Biochemical Pharmacology|June 9, 2004
Cloning and functional expression of a novel marmoset cytochrome P450 2D enzyme, CYP2D30: comparison with the known marmoset CYP2D19Hiroyuki Hichiya, Shino Kuramoto, Shigeo Yamamoto, et al.
The Biochemical Journal|January 22, 2000
Evidence that serine 304 is not a key ligand-binding residue in the active site of cytochrome P450 2D6S W Ellis, G P Hayhurst, T Lightfoot, et al.
Platelets|May 16, 2017
Platelet reactivity influences clot structure as assessed by fractal analysis of viscoelastic propertiesRebecca B Knowles, Matthew J Lawrence, Plinio M Ferreira, et al.
Journal of Thrombosis and Haemostasis : JTH|August 30, 2008
Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2P C J Armstrong, N J Truss, F Y Ali, et al.
Current Drug Metabolism|February 3, 2007
Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liverZoe E Barter, Martin K Bayliss, Philip H Beaune, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 4, 2024
Engineering a Mesoporous Silicon Nanoparticle Cage to Enhance Performance of a Phosphotriesterase Enzyme for Degradation of VX Nerve AgentYi-Sheng Lu, Eduardo Reynoso Moreno, Yubin Huang, et al.
Circulation|December 11, 2014
Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugsBlerina Ahmetaj-Shala, Nicholas S Kirkby, Rebecca Knowles, et al.
Pageof 35